Get started
Author

Arul James

Observed names: A James, A. James, James Arul
ORCID: 0000-0002-2609-6456
Observed ORCID: 0000-0002-2609-6456
OpenAlex ID: A5089171412
Systematic review and meta-analysis of cannabinoids, cannabis-based medicines, and endocannabinoid system modulators tested for antinociceptive effects in animal models of injury-related or pathological persistent pain
2021 · Nadia Soliman, Simon Haroutounian, et al. · Pain · 150
Basic Opioid Pharmacology — An Update
2020 · Arul James, John Williams · British Journal of Pain · 107
Effects of vedolizumab on health‐related quality of life in patients with ulcerative colitis: results from the randomised GEMINI 1 trial
2016 · B. G. Feagan, H. Patel, et al. · Alimentary Pharmacology & Therapeutics · 49
PDF
Effects of Nintedanib on Dyspnea, Cough and Quality of Life in Patients with Progressive Fibrosing Interstitial Lung Diseases: Findings from the INBUILD Trial
2020 · J.J. Swigris, L. Richeldi, et al. · 7
Intermediate Cervical Plexus Block: A Novel Intervention in the Management of Refractory Chronic Neck and Upper Back Pain Following Whiplash Injury: A Case Report
2020 · Arul James, G. Niraj · A&A Practice · 7
Op0115 Effect of Nintedanib on Progression of Interstitial Lung Disease (ild) in Patients With Autoimmune Disease-related Ilds: Further Data From the Inbuild Trial
2020 · E. Matteson, C. Kelly, et al. · Annals of the Rheumatic Diseases · 6
PDF
P209 Long-term effectiveness and safety of vedolizumab in patients with ulcerative colitis: 5-year cumulative exposure of GEMINI 1 completers rolling into the GEMINI open-label extension study
2017 · E.V. Loftus, J.-F. Colombel, et al. · Journal of Crohn s and Colitis · 6
Thu0189 Efficacy and Safety of Nintedanib in Patients With Autoimmune Disease-related Interstitial Lung Disease Treated With Dmards And/or Glucocorticoids at Baseline
2020 · M. Aringer, J. Pope, et al. · Annals of the Rheumatic Diseases · 4
PDF
DOP026 Sustained remission with vedolizumab in patients with moderately to severely active ulcerative colitis: a GEMINI 1 post hoc analysis of week 14 remitters
2017 · A. Stallmach, B. Bokemeyer, et al. · Journal of Crohn s and Colitis · 2
PDF
PTH-052 Efficacy of Vedolizumab with and Without Continued Immunosuppressant Use in Gemini 1 and Gemini 2
2016 · B Feagan, C Siegel, et al. · 2
Risk of infection within 4 weeks of corticosteroid injection (CSI) in the management of chronic pain during a pandemic: a cohort study in 216 patients
2021 · Arul James, Shruti Niraj, et al. · Scandinavian Journal of Pain · 1
Continued Treatment with Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD): Data from the SENSCIS-ON Trial
2021 · K.B. Highland, M.C. Vonk, et al. · 1
Effects of nintedanib on dyspnoe, cough and quality of life in patients with progressive fibrosing interstitial lung diseases: findings from the INBUILD trial*
2021 · M Kreuter, J J Swigris, et al. · Pneumologie · 1
Sat0157 Nintedanib Dose Adjustments and Adverse Events in Patients With Progressive Autoimmune Disease-related Interstitial Lung Diseases in the Inbuild Trial
2020 · E. Volkmann, I. Castellví, et al. · Annals of the Rheumatic Diseases · 1
PDF
EP068 Immersive technology in regional anaesthesia – an objective evaluation of VR USG anaesthetists training platform https://www.arira.co.uk/
2025 · Vikas Gulia, Kausik Dasgupta, et al.
A Novel Technique for Sacroiliac Joint Radiofrequency Ablation: Combining Ultrasound and X-Ray Annotation for Enhanced Precision and Patient Comfort
2024 · Arul James, Manish Mittal, et al. · Journal of Clinical Practice and Medical Case Report.
PDF
Traitement continu par nintedanib chez des patients présentant une pneumopathie interstitielle diffuse associée à la sclérodermie systémique (PID-ScS) : données à trois ans de SENSCIS-ON
2023 · Y. Allanore, M. Vonk, et al. · Revue du Rhumatisme
Pos0126 Continued Treatment With Nintedanib in Patients With Systemic Sclerosis-associated Interstitial Lung Disease (ssc-ild): Three-year Data From Senscis-on
2023 · Y. Allanore, M. Vonk, et al. · Annals of the Rheumatic Diseases
PDF
High dose epinephrine in the management of life-threatening hypotension from post-surgical hemorrhage with an excellent outcome in a patient with Phaeochromocytoma: A case report
2022 · James Arul, Robertson Gavin, et al. · Journal of Surgery and Surgical Research
PDF
Continued Treatment with Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD): Interim Analysis of SENSCIS-ON
2021 · S Gläser, Y Allanore, et al. · Pneumologie
PTH-072 Corticosteroid Dose Reduction in Ulcerative Colitis Patients Treated with Vedolizumab
2016 · E Loftus, C Siegel, et al.
PWE-020 Corticosteroid Dose Reduction with Vedolizumab Treatment of Crohn’s Disease
2016 · E Loftus, C Siegel, et al.
Works count: 22
Citation count: 344
H-index: 6
I10-index: 3
Year
Topic
Type